India’s pharma and chemical industries face challenges scaling from lab to plant due to fragmented data and manual processes. Digital tools like Revvity Signals streamline workflows, boost compliance, and accelerate commercialization.
This article highlights how scientific data strategy is becoming a boardroom priority in Indian biopharma, driving compliance, faster approvals, and global competitiveness through digitized lab systems and robust data infrastructure.
We'd like to show you notifications for the latest news and updates.